These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7644656)

  • 21. [The course of the disease in endocrine orbitopathy. Magnetic resonance tomographic documentation].
    Hosten N; Schörner W; Lietz A; Wenzel KW
    Rofo; 1992 Sep; 157(3):210-4. PubMed ID: 1391813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined cyclosporin-A and methylprednisolone treatment of Graves' ophthalmopathy.
    Leövey A; Bakó G; Szabó J; Kálmán K; Fórizs E
    Acta Med Hung; 1992-1993; 49(3-4):179-85. PubMed ID: 1345455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The combined therapy of Basedow's ophthalmopathy with retrobulbar radiotherapy and i.v. immunoglobulins. The preliminary results].
    Antonelli A; Saracino A; Alberti B; Melosi A; Cartei F; Lepri A; Laddaga M; Baschieri L
    Clin Ter; 1992 Jan; 140(1):25-31. PubMed ID: 1526094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indications and results of prednisone treatment in thyroid ophthalmopathy.
    Apers RC; Oosterhuis JA; Bierlaagh JJ
    Ophthalmologica; 1976; 173(3-4):163-7. PubMed ID: 989888
    [No Abstract]   [Full Text] [Related]  

  • 25. Methylprednisolone increases plasma leptin levels in Graves' hyperthyroidism patients with active Graves' ophthalmopathy.
    Song YM; Lee WJ; Chen MD; Kao CH; Sheu WH
    Horm Metab Res; 2000 Jul; 32(7):277-82. PubMed ID: 10965934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy.
    Higashiyama T; Nishida Y; Morino K; Ugi S; Nishio Y; Maegawa H; Ohji M
    Jpn J Ophthalmol; 2015 Mar; 59(2):124-30. PubMed ID: 25448468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The influence of treatment of progressive edematous infiltrative ophthalmopathy on intraocular pressure].
    Rutecka-Debniak A; Krzystolik Z; Pilarska K; Krzyzanowska-Swiniarska B; Syrenicz A; Jarema A
    Klin Oczna; 1999; 101(3):195-200. PubMed ID: 10526444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Magnetic resonance tomographic differentiation of ocular muscle changes in endocrine orbitopathy].
    Hosten N; Cordes M; Sander B; Schörner W; Wenzel KW; Felix R
    Rofo; 1990 Apr; 152(4):388-92. PubMed ID: 2160096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.
    Wakelkamp IM; Baldeschi L; Saeed P; Mourits MP; Prummel MF; Wiersinga WM
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):323-8. PubMed ID: 16117821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prediction for effectiveness of steroid pulse therapy by MRI in Graves' ophthalmopathy].
    Sato M; Hiromatsu Y; Tanaka K; Nonaka K; Kojima K; Nishimura H; Nishida H
    Nihon Naibunpi Gakkai Zasshi; 1992 Mar; 68(3):143-53. PubMed ID: 1582520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Short-tau inversion-recovery (STIR) sequence magnetic resonance imaging evaluation of orbital structures in Graves' orbitopathy].
    Rodríguez-González N; Pérez-Rico C; López-Para Giménez R; Arévalo-Serrano J; Del Amo García B; Calzada Domingo L; Flores Ruiz L; Blanco R
    Arch Soc Esp Oftalmol; 2011 Nov; 86(11):351-7. PubMed ID: 22040641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Retrobulbar irradiation of endocrine ophthalmopathy: a comparison between 10 and 16 Gy total dose].
    Pfluger T; Wendt T; Toroutoglou N; Pickardt C; Wuttge R
    Strahlenther Onkol; 1990 Oct; 166(10):673-7. PubMed ID: 2237752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma exchange therapy for severe Graves' ophthalmopathy.
    Glinoer D; Schrooyen M
    Horm Res; 1987; 26(1-4):184-9. PubMed ID: 3596467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of Basedow's ophthalmopathy: a comparative evaluation of systemic or retrobulbar administration of corticosteroids associated with orbital radiotherapy].
    Pinchera A; Bartalena L; Marcocci C; Panicucci M; Gianchecchi D; Cavallacci G; Lepri A; Della Maggiora S; Marconcini C; Laddaga M
    Ann Ital Med Int; 1988; 3(1):19-25. PubMed ID: 3152833
    [No Abstract]   [Full Text] [Related]  

  • 36. Levator palpebrae superioris muscle: MR evaluation of enlargement as a cause of upper eyelid retraction in Graves disease.
    Ohnishi T; Noguchi S; Murakami N; Nakahara H; Hoshi H; Jinnouchi S; Futami S; Nagamachi S; Watanabe K
    Radiology; 1993 Jul; 188(1):115-8. PubMed ID: 8511284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy.
    Yokoyama N; Nagataki S; Uetani M; Ashizawa K; Eguchi K
    Thyroid; 2002 Mar; 12(3):223-7. PubMed ID: 11952043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose intravenous steroid pulse therapy in thyroid-associated ophthalmopathy.
    Tagami T; Tanaka K; Sugawa H; Nakamura H; Miyoshi Y; Mori T; Nakao K
    Endocr J; 1996 Dec; 43(6):689-99. PubMed ID: 9075609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of radiotherapy for Graves' ophthalmopathy.
    Konishi J; Iida Y; Kasagi K; Misaki T; Arai K; Endo K; Amemiya T; Abe M; Torizuka K
    Endocrinol Jpn; 1986 Oct; 33(5):637-44. PubMed ID: 3830071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
    Brauer VF; Scholz GH
    Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.